IFITM3 promotes cancer cell proliferation, migration, and metastasis through the TGFβ signaling pathway in prostate cancer cells [49] and facilitates type 2 helper T cell differentiation [50] as well as tumor-associated antigen presentation [51]. Here, IFITM3 is linked to neoplasm.